Superworth

Jasper Therapeutics market cap JSPR

Share price times shares outstanding: what the whole company sells for, since 2020.

Today, Nov 2, 2026
$16.9M
Highest close in our data
$444.4M
Apr 2024

Jasper Therapeutics is worth $16.9M at the close on Nov 2, 2026, at $0.51 a share.

That is down 42% over the last year and down 85% over five years.

Its highest close in our data was $444.4M in Apr 2024.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$16.9M$9.5M$51.5M−66%
2025$49.3M$28.9M$289.1M−85%
2024$333.8M$78.7M$444.4M+279%
2023$88M$54M$218.8M+380%
2022$18.3M$18.3M$258.2M−94%
2021$297.1M$99.5M$372.9M+137%
2020$125.1M$118.8M$128.1Mn/a

Against its peers

Companies in Healthcare nearest Jasper Therapeutics' size, closest first, today.

CompanyMarket cap
JSPRJasper Therapeutics$16.9M
NEPHNephros$35.2M
ATNMActinium Pharmaceuticals$45M
APTAlpha Pro Tech$56.3M
SPROSpero Therapeutics$60.6M
LFVNLifevantage$73.5M
ICCCImmucell$95.9M
KEQUKewaunee Scientific$96.7M
Peer median$60.6M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Jasper Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.